Personal tools

MCL coexpression mm9:2532: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000073!1.00e-18!54;UBERON:0001017!1.23e-17!73;UBERON:0001049!3.52e-17!52;UBERON:0005068!3.52e-17!52;UBERON:0006241!3.52e-17!52;UBERON:0007135!3.52e-17!52;UBERON:0010314!6.03e-17!92;UBERON:0001016!1.06e-16!75;UBERON:0002346!1.79e-16!64;UBERON:0003075!1.79e-16!64;UBERON:0007284!1.79e-16!64;UBERON:0002020!2.93e-16!34;UBERON:0003080!9.42e-15!40;UBERON:0002780!2.40e-14!39;UBERON:0001890!2.40e-14!39;UBERON:0006240!2.40e-14!39;UBERON:0003056!2.61e-14!49;UBERON:0002616!5.36e-14!46;UBERON:0003528!2.67e-13!29;UBERON:0002791!2.67e-13!29;UBERON:0001893!2.67e-13!29;UBERON:0004121!2.89e-13!95;UBERON:0000924!2.89e-13!95;UBERON:0006601!2.89e-13!95;UBERON:0000955!3.12e-13!47;UBERON:0006238!3.12e-13!47;UBERON:0010371!2.78e-12!73;UBERON:0000025!1.11e-09!114;UBERON:0000956!5.39e-09!21;UBERON:0001869!5.39e-09!21;UBERON:0000203!5.39e-09!21;UBERON:0004111!8.90e-08!122;UBERON:0002021!1.66e-07!10;UBERON:0000411!1.66e-07!10;UBERON:0001950!1.66e-07!10;UBERON:0002619!1.99e-07!17
|ontology_enrichment_uberon=UBERON:0000073!1.00e-18!54;UBERON:0001017!1.23e-17!73;UBERON:0001049!3.52e-17!52;UBERON:0005068!3.52e-17!52;UBERON:0006241!3.52e-17!52;UBERON:0007135!3.52e-17!52;UBERON:0010314!6.03e-17!92;UBERON:0001016!1.06e-16!75;UBERON:0002346!1.79e-16!64;UBERON:0003075!1.79e-16!64;UBERON:0007284!1.79e-16!64;UBERON:0002020!2.93e-16!34;UBERON:0003080!9.42e-15!40;UBERON:0002780!2.40e-14!39;UBERON:0001890!2.40e-14!39;UBERON:0006240!2.40e-14!39;UBERON:0003056!2.61e-14!49;UBERON:0002616!5.36e-14!46;UBERON:0003528!2.67e-13!29;UBERON:0002791!2.67e-13!29;UBERON:0001893!2.67e-13!29;UBERON:0004121!2.89e-13!95;UBERON:0000924!2.89e-13!95;UBERON:0006601!2.89e-13!95;UBERON:0000955!3.12e-13!47;UBERON:0006238!3.12e-13!47;UBERON:0010371!2.78e-12!73;UBERON:0000025!1.11e-09!114;UBERON:0000956!5.39e-09!21;UBERON:0001869!5.39e-09!21;UBERON:0000203!5.39e-09!21;UBERON:0004111!8.90e-08!122;UBERON:0002021!1.66e-07!10;UBERON:0000411!1.66e-07!10;UBERON:0001950!1.66e-07!10;UBERON:0002619!1.99e-07!17
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.193418,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,1.1146,0.841386,0.64294,0.380786,0.825437,1.24901,0.575271,0.411696,0.608816,0.444545,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.724277,0.610669,0.474221,0.788421,1.05665,0.859154,0.663409,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.284975,1.44925,0.416814,0.402065,0.411601,1.04436,1.20986,0.684144,0.476502,1.16055,1.00151,0.459035,1.32978,0.181575,0.195254,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.212464,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.38417,0.260379,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.135528
}}
}}

Revision as of 21:33, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:127906334..127906344,+p@chr10:127906334..127906344
+
Mm9::chr12:25667134..25667151,+p@chr12:25667134..25667151
+
Mm9::chr16:38220202..38220213,+p@chr16:38220202..38220213
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
regional part of nervous system1.00e-1854
central nervous system1.23e-1773
neural tube3.52e-1752
neural rod3.52e-1752
future spinal cord3.52e-1752
neural keel3.52e-1752
structure with developmental contribution from neural crest6.03e-1792
nervous system1.06e-1675
neurectoderm1.79e-1664
neural plate1.79e-1664
presumptive neural plate1.79e-1664
gray matter2.93e-1634
anterior neural tube9.42e-1540
regional part of forebrain2.40e-1439
forebrain2.40e-1439
future forebrain2.40e-1439
pre-chordal neural plate2.61e-1449
regional part of brain5.36e-1446
brain grey matter2.67e-1329
regional part of telencephalon2.67e-1329
telencephalon2.67e-1329
ectoderm-derived structure2.89e-1395
ectoderm2.89e-1395
presumptive ectoderm2.89e-1395
brain3.12e-1347
future brain3.12e-1347
ecto-epithelium2.78e-1273
tube1.11e-09114
cerebral cortex5.39e-0921
cerebral hemisphere5.39e-0921
pallium5.39e-0921
anatomical conduit8.90e-08122
occipital lobe1.66e-0710
visual cortex1.66e-0710
neocortex1.66e-0710
regional part of cerebral cortex1.99e-0717


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}